Company intelligence / Profile preview

MJN Neuroserveis

Blanes, Catalonia, Spainmjn.cat ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

MJN Neuroserveis is a Spanish healthtech startup specializing in AI-driven wearable devices to improve the quality of life for people with neurological diseases. Its flagship product, mjn-SERAS, is a non-invasive ear-worn EEG device that predicts epileptic seizures using machine learning algorithms. The device has been commercialized in Europe through Neuraxpharm. Another product, mjn-DREAMER, aims at early Alzheimer's detection and is currently undergoing regulatory review. The company leverages big data analytics and IoT technologies to deliver real-time patient monitoring solutions.

Therapeutic areas: Neurology
Modalities: DeviceWearable deviceDigital health solution
Industry: Physiological Monitoring

Partnerships

NeuraxpharmEIT HealthBridgehead EuropeEIT KIC PartnersClínica CorachanMWC

Beyond the preview

Go deeper on MJN Neuroserveis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MJN Neuroserveis.

Explore the full profile